Polymorphism of the type 6 adenylyl cyclase gene and cardiac hypertrophy

J Cardiovasc Pharmacol. 2003 Dec:42 Suppl 1:S27-32. doi: 10.1097/00005344-200312001-00008.

Abstract

We investigated whether polymorphism of the type 6 adenylyl cyclase gene influences the occurrence of left ventricular hypertrophy in a Japanese population. Type 6 adenylyl cyclase is a major cardiac adenylyl cyclase isoform and plays an important role in regulating cardiac function. We examined the type 6 adenylyl cyclase gene for single nucleotide polymorphism by heteroduplex analysis and found a mutation (T11215A) in intron 17. We genotyped the single nucleotide polymorphism (TT/TA/AA groups) by the mutagenically separated polymerase chain reaction method in 2068 subjects who underwent health screening for cardiovascular disease. Genetic variation was in the Hardy-Weinberg equilibrium. We found no significant association between the frequency of left ventricular hypertrophy and any of the genotype groups. In the TT and the TA genotype group, however, left ventricular hypertrophy was associated with increased blood pressure, while no association with increased blood pressure was found in the AA genotype group. It was concluded that the AA group may be at risk of developing left ventricular hypertrophy independent of increased blood pressure.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenylyl Cyclases / genetics*
  • Adult
  • DNA Mutational Analysis / methods
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Hypertrophy, Left Ventricular / diagnosis
  • Hypertrophy, Left Ventricular / physiopathology*
  • Japan
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics*

Substances

  • Adenylyl Cyclases
  • adenylyl cyclase 6